I think it's really about how research funding is allocated and prioritized. We certainly see that pregnancy is often the stage of life where women are excluded from clinical trials. The reason I called this a bold trial is it was incredibly groundbreaking to have the guts to try an early-stage drug. However, it was because of the high rate of infection in the infants and the death rate associated with that. It forced a really bold and advanced move. Unfortunately we haven't seen that follow-up. New medicine, new vaccines over and over again...we're not seeing the trials in pregnancy early enough to understand safety.
On May 2nd, 2024. See this statement in context.